sorafenib has been researched along with Neoplasms, Skull in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhary, D; Goel, M; Patkar, S; Shrikhande, SV | 1 |
| Clerc, J; Coriat, R; Goldwasser, F; Mir, O; Ropert, S | 1 |
2 other study(ies) available for sorafenib and Neoplasms, Skull
| Article | Year |
|---|---|
Metastasis from Hepatocellular Carcinoma Masquerading as a Jugular Paraganglioma.
Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Hepatocellular; Diagnosis, Differential; Glomus Jugulare Tumor; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Palliative Care; Skull Neoplasms; Sorafenib; Temporal Bone | 2018 |
A painful cranial bulge.
Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Benzenesulfonates; Brain Neoplasms; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Middle Aged; Niacinamide; Occipital Bone; Pain; Parietal Bone; Phenylurea Compounds; Pyridines; Skull Neoplasms; Sorafenib; Temporal Bone; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |